July 5, 2010 / 11:15 PM / 9 years ago

Australia's Sigma says no formal proposal from Aspen

SYDNEY, July 6 (Reuters) - Australian drug maker Sigma Pharmaceuticals SIP.AX said on Tuesday it had not received any formal proposal South Africa’s Aspen Pharmacare (APNJ.J) but Aspen wished to continue conducting due diligence.

Aspen in May bid $570 million for debt-laden Sigma and agreed to conduct due diligence. Aspen’s exclusivity period for Sigma expired on July 5. (Reporting by Michael Smith)

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below